How CRISPR is Revolutionizing the Treatment of Genetic Diseases
Archived series ("Inactive feed" status)
When? This feed was archived on May 11, 2019 03:50 (). Last successful fetch was on January 08, 2019 01:52 ()
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 170748902 series 1302885
The recent buzz around CRISPR-Cas9, a genome editing tool, has revolved around its potential for treating various genetic diseases, including cancer. Jack Hopwood, Intellectual Property Consultant and Bertrand Sautier, Strategic Account Manager at Clarivate Analytics talk about how research activity around CRISPR is being measured by tracking R&D strategies and patents. You will also hear about the importance of protecting intellectual property to help accelerate the pace of innovation and minimize the risk of running into costly disputes.
8 episodes